Question 1

Which countries lead Synthesis and Biological Evaluation research?

Accepted Answer

By volume, India and China publish the most (979 and 912 works in 2022-now).

Question 2

Which institutions lead Synthesis and Biological Evaluation research?

Accepted Answer

By volume in 2022-now, Russian Academy of Sciences publishes the most Synthesis and Biological Evaluation research, followed by Council of Scientific and Industrial Research and Chinese Academy of Sciences.

Question 3

Who are the leading researchers in Synthesis and Biological Evaluation?

Accepted Answer

The most-cited researchers publishing on Synthesis and Biological Evaluation include Michaël Grätzel, Richard A. Gibbs and Jeremy Grimshaw.

Question 4

Where is Synthesis and Biological Evaluation research done?

Accepted Answer

The largest centres of Synthesis and Biological Evaluation research in 2022-now are Moscow (Russia), Beijing (China), Hyderabad (India) and Cairo (Egypt). Among places with at least 20 works in it, it is an unusually large share of all research in Visakhapatnam.

Question 5

Where is the best place to study Synthesis and Biological Evaluation?

Accepted Answer

Among universities, judged by research, Al-Azhar University, Cairo University and King Saud University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Synthesis and Biological Evaluation research growing?

Accepted Answer

Output in 2022-2025 was 0% higher than in 2018-2021, peaking in 2010. The fastest-growing topics are Synthesis and Biological Evaluation.

Question 7

What are the most cited papers in Synthesis and Biological Evaluation?

Accepted Answer

The most cited paper in Synthesis and Biological Evaluation is "Fluorine in medicinal chemistry" (Sophie Purser, Peter R. Moore, Steve Swallow et al., 2007), with 7,580 citations. Next come "Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals" (6,486) and "Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)" (4,838).